# An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

> clinical trial · VERIFIED · 2026-07-06

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Non-Hodgkins Lymphoma

- Company: Hoffmann-La Roche
- Sector: Non-Hodgkins Lymphoma
- Primary source: https://clinicaltrials.gov/study/NCT03533283

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.